ABSTRACT
Five pyridyl-ß-diketones were synthesized by Claisen condensation of ethyl nicotinate with various aryl methyl ketones in benzene in the presence of sodium amide as the base, and then reacted with boron trifluoride diethyl etherate in dichloromethane to afford some new boron difluoride pyridyl-ß-diketonate derivatives. The compounds obtained were characterized using FTIR, (1)H NMR, elemental analysis and mass spectrometry. Their optical properties were studied in DMF by UV-vis absorption and fluorescence spectroscopy. The results showed that these boron complexes exhibited intense fluorescence in the blue-green region (420-490 nm) under UV radiation with a relatively high quantum yield. Especially, compounds 4b and 5b displayed much higher quantum yield as compared to compounds 1b, 2b and 3b.
Subject(s)
Boron Compounds/chemistry , Boron Compounds/chemical synthesis , Pyridines/chemistry , Pyridines/chemical synthesis , Quantum Theory , Spectrometry, Fluorescence , Spectrophotometry, UltravioletABSTRACT
OBJECTIVE: To explore the levels of serum GP73 in patients with fatty liver disease. METHODS: The sera GP73 were determined by ELISA in 178 patients with fatty liver disease and 100 healthy controls. RESULTS: Serum GP73 levels were significantly increased in patients with various fatty liver diseases(70.62 +/- 60.60 ng/ml), compared with those of control population (35.61 +/- 12.22 ng/ml). In patients with alcoholic fatty liver disease, acute liver injury, chronic hepatitis B, and non-alcoholic fatty liver disease, their serum GP73 concentration were 81.86 +/- 47.82 ng/ml, 82.77 +/- 77.73 ng/ml, 63.84 +/- 50.62 ng/ml, and 65.75 +/- 62.20 ng/ml, respectively. But no significant difference was found between these groups (P > 0.05). In 68 patients with F > or = 1.0 (71.46 +/- 66.48 ng/ml), 75 patients with F> or = 2.0 (69.58 +/- 62.31 ng/ml), and 34 patients with F3-F4 (71.65 +/- 43.89 ng/ml), there were also no marked differences was observed between these fatty groups (F = 0.02, P = 0.98). CONCLUSION: Serum GP73 levels were increased in patients with different liver diseases, but its concentrations were seems not related with degree of fatty injury.
